Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
Authors
Keywords
-
Journal
Nature Biomedical Engineering
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-05
DOI
10.1038/s41551-020-00656-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
- (2019) Morgan L. Maeder et al. NATURE MEDICINE
- Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing
- (2019) Baisong Lu et al. NUCLEIC ACIDS RESEARCH
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome
- (2019) Olaya Santiago-Fernández et al. NATURE MEDICINE
- Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome
- (2019) Ergin Beyret et al. NATURE MEDICINE
- Three-year follow-up of Phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age related macular degeneration
- (2019) E.P. Rakoczy et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations
- (2019) Reza Shahbazi et al. NATURE MATERIALS
- Low risk to retina from sustained suppression of VEGF
- (2019) Peter A. Campochiaro JOURNAL OF CLINICAL INVESTIGATION
- Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better
- (2019) Ayumi Usui-Ouchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Continuous evolution of base editors with expanded target compatibility and improved activity
- (2019) Benjamin W. Thuronyi et al. NATURE BIOTECHNOLOGY
- Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient ‘hit-and-run’ genome editing
- (2019) Pin Lyu et al. NUCLEIC ACIDS RESEARCH
- Minimap2: pairwise alignment for nucleotide sequences
- (2018) Heng Li BIOINFORMATICS
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction
- (2018) Luke W Koblan et al. NATURE BIOTECHNOLOGY
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- Accurate detection of complex structural variations using single-molecule sequencing
- (2018) Fritz J. Sedlazeck et al. NATURE METHODS
- CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- (2018) Taeyoung Koo et al. Nature Communications
- High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
- (2018) Duran Sürün et al. Molecular Therapy-Nucleic Acids
- VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
- (2018) Claudia Montagna et al. Molecular Therapy-Nucleic Acids
- Time-Restricted PiggyBac DNA Transposition by Transposase Protein Delivery Using Lentivirus-Derived Nanoparticles
- (2018) Kristian Alsbjerg Skipper et al. Molecular Therapy-Nucleic Acids
- Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
- (2018) Bumwhee Lee et al. Nature Biomedical Engineering
- In vivo CRISPR editing with no detectable genome-wide off-target mutations
- (2018) Pinar Akcakaya et al. NATURE
- Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
- (2018) Ruslan Grishanin et al. MOLECULAR THERAPY
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
- (2018) Ang Li et al. Molecular Therapy-Methods & Clinical Development
- AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization
- (2018) Chris P. Hughes et al. Molecular Therapy-Methods & Clinical Development
- Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
- (2017) Kyoungmi Kim et al. GENOME RESEARCH
- Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
- (2017) Peter A. Campochiaro et al. HUMAN GENE THERAPY
- Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
- (2017) Xue Gao et al. NATURE
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells
- (2017) Andreas Holmgaard et al. Molecular Therapy-Nucleic Acids
- Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
- (2017) Pavel I. Ortinski et al. Molecular Therapy-Methods & Clinical Development
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Cas-analyzer: an online tool for assessing genome editing results using NGS data
- (2016) Jeongbin Park et al. BIOINFORMATICS
- Lentiviral Delivery of Proteins for Genome Engineering
- (2016) Yujia Cai et al. CURRENT GENE THERAPY
- Lentivirus pre-packed with Cas9 protein for safer gene editing
- (2016) J G Choi et al. GENE THERAPY
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Lentiviral vectors, two decades later
- (2016) L. Naldini et al. SCIENCE
- CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
- (2016) Ferdy R. van Diemen et al. PLoS Pathogens
- Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
- (2016) Bleranda Zeka et al. Acta Neuropathologica Communications
- Adenovirus-Mediated Somatic Genome Editing ofPtenby CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
- (2015) Dan Wang et al. HUMAN GENE THERAPY
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles
- (2015) Anne Prel et al. Molecular Therapy-Methods & Clinical Development
- CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool
- (2015) Manuel Stemmer et al. PLoS One
- Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice
- (2015) Yan Gong et al. PLoS One
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- Life of psi: How full-length HIV-1 RNAs become packaged genomes in the viral particles
- (2014) Malika Kuzembayeva et al. VIROLOGY
- Delivering the second revolution in site-specific nucleases
- (2014) Perry B Hackett et al. eLife
- Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
- (2014) Yujia Cai et al. eLife
- DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors
- (2013) Yujia Cai et al. NUCLEIC ACIDS RESEARCH
- Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
- (2013) F. Mingozzi et al. Science Translational Medicine
- Targeted deletion of Vegfa in adult mice induces vision loss
- (2012) Toshihide Kurihara et al. JOURNAL OF CLINICAL INVESTIGATION
- Age-related macular degeneration
- (2012) Laurence S Lim et al. LANCET
- BEDTools: a flexible suite of utilities for comparing genomic features
- (2010) Aaron R. Quinlan et al. BIOINFORMATICS
- Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
- (2010) Alaaldin M. Alkilany et al. JOURNAL OF NANOPARTICLE RESEARCH
- Protein transduction from retroviral Gag precursors
- (2010) Christine Voelkel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Choroidal Neovascularization via Brief Subretinal Exposure to a Newly Developed Lentiviral Vector Pseudotyped with Sendai Viral Envelope Proteins
- (2009) Yusuke Murakami et al. HUMAN GENE THERAPY
- Hybrid Lentivirus-transposon Vectors With a Random Integration Profile in Human Cells
- (2009) Nicklas H Staunstrup et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now